SCHEMBL4917013

SCHEMBL4917013

O=c1[nH]c2ccccc2n1Cc1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 1.00
HTT P42858 2/20 1.00
CYP1A2 P05177 2/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
PGR P06401 2/20 0.57
OPRM1 P35372 2/20 0.56
APOBEC3G Q9HC16 1/20 0.55
ALDH1A1 P00352 3/20 0.54
HPGD P15428 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
KDM4E B2RXH2 2/20 0.54
HTR1A P08908 1/20 0.53
HTR7 P34969 1/20 0.53
MAPT P10636 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
IDO1 P14902 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
POLB P06746 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2762074 0.90 LMNA (0.81) LMNAHTTCYP1A2MEN1KMT2A
SCHEMBL4920376 0.86 LMNA (0.76) LMNAHTTCYP1A2MEN1KMT2A
SCHEMBL23997482 0.86 LMNA (0.75) LMNAHTTCYP1A2MEN1KMT2A
SCHEMBL30345072 0.86 LMNA (0.75) LMNAHTTCYP1A2MEN1KMT2A
SCHEMBL23997276 0.86 LMNA (0.75) LMNAHTTCYP1A2MEN1KMT2A
SCHEMBL31325551 0.86 LMNA (0.75) LMNAHTTCYP1A2MEN1KMT2A
SCHEMBL10143728 0.85 LMNA (0.74) LMNAHTTCYP1A2MEN1KMT2A
SCHEMBL4915141 0.83 LMNA (0.70) LMNAHTTCYP1A2MEN1KMT2A
SCHEMBL23997385 0.82 LMNA (0.69) LMNAHTTCYP1A2MEN1KMT2A
SCHEMBL23997320 0.82 LMNA (0.69) LMNAHTTCYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058376-A1 PIPERIDINES ICAGEN, INC. (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058376-A1 PIPERIDINES TRPV3, SCN3A, TRPV1 LMNA 2484/4885HTT 1281/4885CYP1A2 3200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.